SECTION V. LABELING
UNIVERSAL SYMBOL STILL WAITING DESIGN APPROVAL AS OF 4/5/2017
Draft 1-26-2017 This draft is a working document. All information contained herein is subject to change and may differ substantially from the final document. The information contained in this document should not be considered the position or views of the agency or the Governor.
(A) The purpose of this section is to set the minimum standards for the labeling of usable marijuana that is sold to a qualifying patient or designated caregiver by a dispensary or given by a qualifying patient or designated to another qualifying patient or designated caregiver.
(1) Usable marijuana received or transferred by a dispensary, qualifying patient or designated caregiver must meet the labeling requirements in these rules.
(2) (a) A dispensary must return usable marijuana that does not meet labeling requirements in these rules to the individual who transferred it to the dispensary and document to whom the item was returned, what was returned and the date of the return; or
(b) Dispose of any usable marijuana that does not meet labeling requirements and that cannot be returned in a manner specified by the Department.
(B) Usable Marijuana Labeling Requirements
(1) Prior to usable marijuana being sold or transferred to a qualifying patient or designated caregiver, the container holding the usable marijuana must have a label that has the following information:
(a) Producer‟s business or trade name and cultivation center or dispensary number;
(b) Business or trade name of cultivation center or dispensary or cultivation center or dispensary that packaged or distributed the product, if different from the producer;
(c) A unique identification number;
(d) Date of harvest;
(e) Name of strain;
(f) Net weight in U.S. customary and metric units;
(g) Concentration of THC and CBD;
(h) Activation time expressed in words or through a pictogram;
(i) Name of the lab that performed any test, any associated test batch number and any test analysis date;
(j) Universal symbol;
Draft 1-26-2017 This draft is a working document. All information contained herein is subject to change and may differ substantially from the final document. The information contained in this document should not be considered the position or views of the agency or the Governor.
(k) A warning that states: "For use by qualified patients only. Keep out of reach of children.";
(l) A warning that states: “Marijuana use during pregnancy or breastfeeding poses potential harms.”; and
(m) A warning that states: "This product is not approved by the FDA to treat, cure, or prevent any disease".
(C) Cannabinoid Concentrates and Extracts
(1) Prior to a cannabinoid concentrate or extract being sold or transferred to a qualifying patient or designated caregiver, the container holding the concentrate or extract must have a label that has the following information:
(a) Cultivation center or dispensary‟s business or trade name and cultivation center or dispensary number;
(b) Business or trade name of cultivation center or dispensary that packaged or distributed the product, if different from the cultivation center or dispensary;
(c) A unique identification number;
(d) Product identity (concentrate or extract);
(e) Date the concentrate or extract was made;
(f) Net weight or volume in U.S. customary and metric units;
(g) If applicable, serving size and number of servings per container or amount suggested for use by the qualifying patient at any one time;
(h) Concentration or amount by weight or volume of THC and CBD in each amount suggested for use and in the container;
(i) Activation time, expressed in words or through a pictogram;
(j) Name of the lab that performed any test, any associated test batch number and any test analysis date;
(k) Universal symbol; DESIGN NOT APPROVED YET AS OF 4/1/2017
(l) A statement that reads:
Draft 1-26-2017 This draft is a working document. All information contained herein is subject to change and may differ substantially from the final document. The information contained in this document should not be considered the position or views of the agency or the Governor.
(i) "This product is not approved by the FDA to treat, cure, or prevent any disease";
(ii) "For use by qualifying patients only. Keep out of reach of children.";
(iii) "DO NOT EAT" in bold, capital letters; and (iv) “Marijuana use during pregnancy or breastfeeding poses potential harms.”
